Interview with DecisionRx President Travis Morgan

HealthBiz with David E. Williams

Travis Morgan, President and CFO of DecisionRx touts medication optimization as the way to improve outcomes and reduce costs. In this episode, Travis shares his journey from an entrepreneurial upbringing to making waves in the life sciences and healthcare technology sectors. Learn how his experiences in public accounting and as a precision medicine company co-founder have shaped his unique approach to tackling one of the healthcare industry's most costly issues: ineffective medications.
Hear how DecisionRx is leveraging pharmacogenomics and data science to improve patient outcomes and reduce healthcare expenses. Travis explains the impact of pharmacist-led interventions , and how the value-based care model, combined with genetic analysis, can guides clinical decision to prevent medication failures. Get insights into the commercial success of this approach, particularly within risk-bearing entities like ACOs and Medicare Advantage plans.
Learn about the power of innovative medication optimization, eliminating the usual friction associated with third-party reimbursement. Travis discusses the company's scale-up effort, with over 230,000 lives under contract through accountable care organizations and substantial financial backing from the Carlyle Group.
Finally, hear why Travis recommends "Endurance: The Biography of Ernest Shackleton," as an essential read for any aspiring leader.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.